Skip to main content

Table 1 Clinical data of 12 patients with paraneoplastic anti-NMDA receptor encephalitis

From: Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients

NO

Sex/ age

Hospital stay/d

Prodromal symptom

Psychiatric symptoms

Seizure

Cognitive dysfunction

Speech dysfunction

Movement disorder

Consciousness decreased

Autonomic dysfunction

Central hypoventilation

MRI

EEG

CSF

Anti-NMDAR antibody

Immunotherapy

mRs of follow-up

CSF

Serum

N-1

f/18

57

Headache

Early irritability, manic, aggression and automutilation, disorganized, Late Psychomotor inhibition

GTCS SE

Yes

pressured speech and mutism

choreoathetoid movements

coma

hypotension

Yes

Normal

focal slow activity

Increased white blood cells

+++

++

IVIG 5d * 2

0 (2.5 Year)

N-2

f/19

106

Fever

hallucination, agitation, irritability

GTCS

Yes

pressured speech

Orofacial dyskinesia, Myoclonus

delirium, light coma

pyrexia

Yes

Bilateral temporal lobe meningeal thickening

diffuse slow activity and epileptic activity

Increased white blood cells

+++

IVIG 5d * 2

Methylprednisolone

0 (4.2 Year)

N-3

f/17

50

Fever

Disorganized, agitation, manic, insomnia, hallucinations

GTCS

Yes

No

Orofacial dyskinesia

coma

No

No

Normal

epileptic activity

Increased white blood cells

++

+++

IVIG 5d * 2 Methylprednisolone 1000 mg 5d

0 (2.5 Year)

N-4

f/17

73

Have a cold

Agitation, Hallucinations, Delusions

GTCS

Yes

No

No

coma

pyrexia, tachycardia

Yes

meningeal enhancement

focal slow activity

0

+++

+++

Methylprednisolone 500 mg 2d

IVIG 20 g 5d*2

0 (5.5 Year)

N-5

f/28

70

No

Agitation, Hallucinations, Delusions, automutilation

GTCS

Yes

gibberish-speaking

Orofacial dyskinesia, choreoathetoid movements

somnolence, deliration

No

Yes

Normal

diffuse slow activity and extreme delta brush

Increased white blood cells

+++

++

IVIG 5d * 3

Methylprednisolone 1000 mg 3d

1 (1.5 Year)

N-6

f/20

28

Headache

Disorganized, agitation

CPS

Yes

No

Orofacial dyskinesia

light coma

tachycardia

Yes

diffuse slow activity and extreme delta brush

Increased white blood cells and Protein

+++

_

IVIG 5d * 3

Methylprednisolone 1000 mg 5d

0 (2.4 Year)

N-7

f/22

27

insomnia

Agitation, Hallucinations, Delusions, Disorganized, automutilation

CPS

Yes

No

Orofacial dyskinesia

No

urinary incontinence

No

Normal

diffuse slow activity

0

+++

++

IVIG 5d Methylprednisolone 500 mg 5d

0 (1.6 Year)

N-8

f/20

58

numbness of fingers

No

SGTCS

Yes

No

finger spasm

No

No

No

Normal

focal slow activity

Increased white blood cells

+++

++

IVIG 5d*2

1 (2 Year)

N-9

f/29

400

Fever

Hallucinations

GTCS

Yes

Orofacial dyskinesia

coma

No

Yes

Abnormal signals in bilateral frontal and temporal lobe

focal slow activity and epileptic activity

Elevated pressure and increased white blood cells

+++

++

IVIG 5d * 4 Rituximab 500 mg * 3

Methylprednisolone 1000 mg 5d

1 (1 Year)

N-10

f/35

23

No

Aggression, Disorganized, Agitation, Manic, Insomnia, Hallucinations, Psychomotor inhibition

CPS SE

Yes

mutism

No

coma

No

Yes

cerebral infarction in Splenium of Corpus Callosum, Right lateral ventricle enlargement

extreme delta brush

0

+++

++

IVIG 5d

0 (3.6 Year)

N-11

f/43

15

No

Aggression, Disorganized, Agitation, Manic

GTCS

Yes

No

No

somnolence

No

No

Normal

diffuse slow activity and extreme delta brush

0

+++

_

IVIG 5d

0 (2 Year)

N-12

m/25

113

Have a cold

Disorganized, Agitation Manic

GTCS

Yes

disfluency

Orofacial dyskinesia

coma

pyrexia

Yes

Abnormal signals in bilateral temporal lobe and amygdala

Normal

Elevated pressure and increased white blood cells

+++

+

IVIG 5d*2

6

  1. f female, m male, GTCS generalized tonic-clonic seizure, SE status epilepticus, CPS complex partial seizure, SGTCS secondary generalized tonic-clonic seizure, negative (−), weakly positive (+, CSF 1:1, serum 1:10), positive (++, CSF 1:10 or 1:32, serum 1:32), strongly positive (+++, CSF 1:100 or 1:320, serum 1:100)